DPP4 and type 2 diabetes mellitus: One such incretin agonist is a dipeptidyl peptidase 4 (DPP-4) inhibitor, such as saxagliptin, first approved by the US Food and Drug Administration, and now widely used in over 66 countries including China as an oral hypoglycaemia agent for type 2 diabetes.